Continuously evolving venues, methods, and targets of patent litigation; the new USPTO director; patent reform bills … these are just a few factors challenging Japanese IP executives’ already complex task of trying to manage their global IP footprint smarter.
In this half-day, complimentary seminar, former USPTO Director Jon W. Dudas and a group of U.S., Japanese, and Chinese IP attorneys experienced in advising Japanese corporations decipher what really matters for Japanese businesses as U.S. patent procurement and enforcement regimes are being radically restructured. The topics included:
- The New Administration and Director Kappos – What Happens Next?
- The effect on the Patent Reform Act of 2009
- What will become of the Tafas v. Doll rules package and the interpretation of Bilski?
- How might the rules on inter partes reexamination be tightened?
- Strategic Use of Inter Partes Reexamination in Patent Litigation
- In synergy with expected procedural changes under the new USPTO director, the very high kill ratio of patents makes inter partes reexamination a very attractive alternative or parallel to district court litigation
- Pros and cons vs. alternatives
- Mistakes to avoid
- Strategic Measures for Effective and Efficient U.S. Patent Litigation
- Focused discovery, management controls, and other tactical measures to achieve litigation goals without undue costs
- Positioning a company to exit litigation early
- Latest considerations for transferring away from certain “Rocket Dockets”
- Chinese Infringement Under the Third Amendment:
- Milestones for claim and patent application drafting and claim interpretation based on the draft interpretation of patent infringement principles issued by the highest court in China
- Comparative analyses of the Chinese patent law with reference to Japanese and U.S. patent principles
Guest Speakers
- Dr. Hiroshi Akimoto, former Managing Director, Takeda Pharmaceutical Company, Ltd.
- Shozo Uemura, former Deputy Director General, WIPO
Foley Speakers
- Jon W. Dudas, former Director of USPTO and Partner, IP Litigation
- Pavan K. Agarwal, Partner and Chair, Electronics
- Etsuo Doi, Partner, Electronics, Tokyo
- Stephen B. Maebius, Partner and Co-Chair, Life Sciences Industry Team
- Prof. Harold C. Wegner, Partner, Chemical & Pharmaceutical
- Yan Zhao, Senior Counsel, Electronics, Shanghai
For specific information on the content of this seminar, contact Konomi Kaji at [email protected].
相关见解
December 12, 2025
Health Care Law Today
Eleventh Circuit Hears Oral Argument in Landmark Constitutional Challenge to False Claims Act’s Qui Tam Provisions
On December 12, the U.S. Court of Appeals for the Eleventh Circuit heard oral argument in U.S. ex rel. Zafirov v. Florida Medical…
2025年12月11日
福莱观点
知识产权组合管理中的反垄断风险与合规策略
本文分析了知识产权组合管理如何在促进创新的同时,也可能带来潜在风险……
2025年12月11日
福莱观点
加州空气资源委员会发布SB 261和SB 253法案的拟议法规
2025年12月9日,加州空气资源委员会(CARB)发布了其针对初始法规的拟议监管文本……